EMCOA
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Everest Metals Corporation Ltd
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
0
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Everest Metals Corporation Ltd - Option Expiring 31-Oct-2023
π Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.00
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in EMCOA
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in EMCOA
N/A
EMCOA investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in EMCOA also invest in...
Want more shares? Try these...
Emyria Ltd. is a healthcare technology and services company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2020-02-12. The firm is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises medication-assisted treatment programs and biopharmaceuticals, specifically methylenedioxy-methylamphetamine (MDMA) analogues and Ultra-Pure cannabidiol (CBD) capsules. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like MDMA-assisted therapy for PTSD. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyriaβs Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.
π Performance (5Yr p.a)
-14.92%
π Share price
$0.03 AUD
π¦ LOGISTICS
Everest Metals Corp. Ltd. engages in the exploration of economic deposits containing cobalt. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-10-18. The company has precious metal, battery metal, and critical mineral projects in Australia. Its projects include Revere Gold Project, Mt Edon Project, Ninghan Project, Rover Project, Mt Dimer Gold & Silver Project, NSW Broken Hill Projects, and Amadeus & Georgina Project. Revere Gold Project is located along an inferred extension of the Andy Well Greenstone Shear System, with the DeGrussa Copper-Gold mine along the strike, approximately 55 kilometers to the north-east. Mt Edon Project is located in the southern portion of the Paynes Find Greenstone Belt, an area known to host swarms of Pegmatites and prospective for critical metals. Ninghan Project sits in Ninghan Fold Belt mafic and ultramafic greenstone with the tenement package covering an area of approximately 228 square kilometers. Rover Project is a tenement holding in Central Yilgarn.
π Performance (5Yr p.a)
-11.75%
π Share price
$0.17 AUD
βοΈ MINING